v3.26.1
Notes Payable - 2025 July Unsecured SPA Notes Narrative (Details)
3 Months Ended 6 Months Ended
Sep. 19, 2025
Jul. 14, 2025
USD ($)
closing
day
$ / shares
shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
Mar. 31, 2026
USD ($)
Mar. 30, 2026
$ / shares
Dec. 31, 2025
USD ($)
Aug. 21, 2025
USD ($)
Aug. 20, 2025
USD ($)
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Debt Instrument [Line Items]                          
Exercise price (in dollars per share) | $ / shares     $ 219.60   $ 219.60                
2025 July Unsecured SPA Notes                          
Debt Instrument [Line Items]                          
Percent of purchaser's conversion shares   33.00%                      
2025 July Unsecured SPA Warrants                          
Debt Instrument [Line Items]                          
Debt instrument, term   5 years                      
2025 July Unsecured SPA Notes                          
Debt Instrument [Line Items]                          
Aggregate principal amount   $ 82,000,000.0               $ 83,500,000 $ 82,000,000.0    
Debt instrument, number of closings | closing   2                      
Debt instrument, term   5 years                      
Contractual interest rates (in percent)   10.00%                      
Debt instrument, redemption price, percentage   10.00%                      
Redemption price, percentage   25.00%                      
Conversion price (in dollars per share) | $ / shares   $ 262.50 252.00   252.00                
Debt instrument, floor price (in dollars per share) | $ / shares     30.00   30.00     $ 30.00          
Debt instrument, convertible, threshold percentage of stock price trigger 100.00%                        
Debt instrument, exercisable, threshold percentage of stock price trigger 120.00%                        
Exercise price (in dollars per share) | $ / shares     $ 303.00   $ 303.00                
2025 July Unsecured SPA Notes | Series B Preferred Stock                          
Debt Instrument [Line Items]                          
Pro rata aggregate cap (in shares) | shares   6,813,785                      
Notes Payable                          
Debt Instrument [Line Items]                          
Notes and loans payable     $ 99,928,000 $ 28,033,000 $ 99,928,000 $ 28,033,000 $ 46,367,000   $ 60,666,000     $ 24,674,000 $ 49,488,000
Gain (loss) on fair value adjustment of debts     $ 3,045,000 (8,723,000) $ (2,167,000) 13,057,000              
Notes Payable | 2025 July Unsecured SPA Notes                          
Debt Instrument [Line Items]                          
Contractual interest rates (in percent)   18.00% 10.00%   10.00%       10.00%        
Redemption price, percentage   8.00%                      
Conversion price (in dollars per share) | $ / shares     $ 58.23   $ 58.23                
Debt instrument, convertible, threshold consecutive trading days | day   5                      
Notes and loans payable     $ 11,655,000 $ 0 $ 11,655,000 0 $ 22,778,000   $ 26,796,000       $ 0
Proceeds from debt, net of issuance costs     0   0                
Debt conversion, converted amount     $ 14,500,000   $ 22,900,000                
Shares issued from conversion (in shares) | shares     399,160   606,416                
Gain (loss) on extinguishment of debt     $ (6,300,000)   $ (9,600,000)                
Gain (loss) on fair value adjustment of debts     $ (225,000)   $ (2,698,000) $ 0